Efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus and established cardiovascular disease using insulin: A VERTIS CV substudy

Medicine & Life Sciences

• 5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1-hydroxymethyl-6,8-dioxabicyclo(3.2.1)octane-2,3,4-triol 100%
• Blood Pressure 32%
• Body Weight 13%
• Cardiovascular Diseases 36%
• Confidence Intervals 7%
• Fasting 10%
• Genitalia 5%
• Glucose 7%
• Glycated Hemoglobin A 6%
• Health Care Outcome Assessment 4%
• Hypoglycemia 6%
• Incidence 6%
• Infections 3%
• Insulin 34%
• Least-Squares Analysis 14%
• Placebos 21%
• Safety 29%
• Therapeutics 1%
• Type 2 Diabetes Mellitus 38%